Cargando…
Integrative Analysis of Biomarkers and Mechanisms in Adamantinomatous Craniopharyngioma
Craniopharyngioma is a benign tumor, and the predominant treatment methods are surgical resection and radiotherapy. However, both treatments may lead to complex complications, seriously affecting patients’ survival rate and quality of life. Adamantinomatous craniopharyngioma (ACP), as one of the his...
Autores principales: | Lin, Da, Zhao, Wenyue, Yang, Jun, Wang, Hao, Zhang, Hongbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006448/ https://www.ncbi.nlm.nih.gov/pubmed/35432485 http://dx.doi.org/10.3389/fgene.2022.830793 |
Ejemplares similares
-
Adamantinomatous craniopharyngioma: evolution in the management
por: Massimi, Luca, et al.
Publicado: (2023) -
Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma
por: Martinez‐Barbera, Juan Pedro
Publicado: (2015) -
Molecular biological features of cyst wall of adamantinomatous craniopharyngioma
por: Zhao, Chuan, et al.
Publicado: (2023) -
A Rare Case of Adamantinomatous Craniopharyngioma in an Adult
por: Carpenter, Emilee A, et al.
Publicado: (2022) -
SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma
por: Carreno, G, et al.
Publicado: (2019)